tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sarepta Therapeutics Inc. (SRPT)
NASDAQ:SRPT
US Market
SRPT
Sarepta Therapeutics
RESEARCH TOOLSreports

Sarepta Therapeutics (SRPT) Stock News & Sentiment

Compare
4,059 Followers
Sarepta Therapeutics: Safety Uncertainty and Label Risk Overshadow Elevidys Data, Supporting Sell/High Risk Rating
Premium
Ratings
Sarepta Therapeutics: Safety Uncertainty and Label Risk Overshadow Elevidys Data, Supporting Sell/High Risk Rating
9d ago
SRPT
Tempered Growth Outlook and Heightened Regulatory Risk Drive Sell Rating on Sarepta Therapeutics
Premium
Ratings
Tempered Growth Outlook and Heightened Regulatory Risk Drive Sell Rating on Sarepta Therapeutics
23d ago
SRPT
Balanced Risk Profile Amid Elevidys Uncertainty and PMO Regulatory Headwinds Supports Hold on Sarepta
Premium
Ratings
Balanced Risk Profile Amid Elevidys Uncertainty and PMO Regulatory Headwinds Supports Hold on Sarepta
24d ago
SRPT
Sarepta Therapeutics: Resilient Fundamentals, Elevidys Recovery, and Pipeline Catalysts Underscore Attractive Buy‑Rated Upside
Premium
Ratings
Sarepta Therapeutics: Resilient Fundamentals, Elevidys Recovery, and Pipeline Catalysts Underscore Attractive Buy‑Rated Upside
24d ago
SRPT
Sarepta Therapeutics Extends Debt Maturities with New Notes
Premium
Company Announcements
Sarepta Therapeutics Extends Debt Maturities with New Notes
2M ago
8K
SRPT
Vertiv, Affirm, Sarepta, Micron, PepsiCo: Trending by Analysts
Premium
Weekend Updates
Vertiv, Affirm, Sarepta, Micron, PepsiCo: Trending by Analysts
2M ago
MU
PEP
Sarepta Therapeutics Refinances Convertible Senior Notes
Premium
Company Announcements
Sarepta Therapeutics Refinances Convertible Senior Notes
2M ago
8K
SRPT
More SRPT News >

SRPT News on the Web

Sarepta receives approval to start SRP-1005 trial in New Zealand
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN)
TipRanks News
Neutral
Sarepta’s SRP-1005 Clinical Trial for Huntington’s Disease Receives Regulatory Green Light—What’s Next for This Innovative RNA Therapy?
Market Chameleon
Neutral
Sarepta assumed with an Equal Weight at Barclays
TipRanks News
Neutral
Bank of America Securities Keeps Their Sell Rating on Sarepta Therapeutics (SRPT)
TipRanks News
Bearish
Sarepta price target raised to $22 from $15 at Baird
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Sarepta Therapeutics (SRPT) and Protagonist Therapeutics (PTGX)
TipRanks News
Bearish
Sarepta Therapeutics: Safety Uncertainty and Label Risk Overshadow Elevidys Data, Supporting Sell/High Risk Rating
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
SRPT
Sector Average
Media Buzz
This Week3 articles
Weekly Average11.25 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SRPT’s Media Buzz Sentiment?
3 articles about SRPT were published this week. In an average week, 11.25 articles are published.
    What is SRPT’s weekly average amount of articles?
    In an average week, 11.25 articles about SRPT are published.
      What is SRPT’s News Sentiment?
      100% of articles about SRPT were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        QNCXQuince Therapeutics
        AZTAAzenta
        INNVInnovAge Holding
        RMDResmed
        Showing the stocks with the most bullish news sentiment over the past week